A detailed history of First Horizon Corp transactions in Abb Vie Inc. stock. As of the latest transaction made, First Horizon Corp holds 69,304 shares of ABBV stock, worth $16 Million. This represents 0.76% of its overall portfolio holdings.

Number of Shares
69,304
Previous 21,979 215.32%
Holding current value
$16 Million
Previous $2.48 Million 548.32%
% of portfolio
0.76%
Previous 0.23%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 24, 2025

BUY
$184.85 - $231.54 $8.75 Million - $11 Million
47,325 Added 215.32%
69,304 $16 Million
Q2 2021

Aug 09, 2021

BUY
$105.21 - $117.21 $35,140 - $39,148
334 Added 1.54%
21,979 $2.48 Million
Q1 2021

May 11, 2021

BUY
$102.3 - $112.62 $105,369 - $115,998
1,030 Added 5.0%
21,645 $2.34 Million
Q4 2020

Feb 11, 2021

BUY
$80.49 - $108.67 $84,755 - $114,429
1,053 Added 5.38%
20,615 $2.21 Million
Q3 2020

Nov 12, 2020

BUY
$85.91 - $100.83 $1.68 Million - $1.97 Million
19,562 New
19,562 $1.71 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $409B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track First Horizon Corp Portfolio

Follow First Horizon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Horizon Corp, based on Form 13F filings with the SEC.

News

Stay updated on First Horizon Corp with notifications on news.